A Bioequivalence Study of Sunitinib Malate Capsules.

Clinical trial NCT05800106 · COMPLETED

Trial details

NCT number: NCT05800106
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Gastrointestinal Stromal Tumors Renal Cell Carcinoma Pancreatic Neuroendocrine Tumor

Start date: 2018-12-04
Primary completion: 2019-01-06
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.